Search results
Results from the WOW.Com Content Network
Health Canada received a submission from Moderna on June 29, 2023, for yet another reformulated COVID-19 vaccine based on the Omicron XBB.1.5 subvariant of SARS-CoV-2. [131] The updated version was tested in a small human trial of 101 participants who had previously received four doses of previous formulations of the Moderna COVID-19 vaccine.
Users of this vaccine passport, the first in Canada, faced fewer COVID-19 public health restrictions. [2] By early July, the demand for the paper vaccine passports temporarily overwhelmed the system. At the same time, the province reached a new "marker in the pandemic"—the COVID-19 vaccines supply exceeded "demand on a daily basis." [2] [44]
In March 2021, amid supply shortages, NACI issued a strong recommendation that second doses of two-dose COVID-19 vaccines (such as the AstraZeneca, Moderna, and Pfizer vaccines) be given up to four months after the first, as opposed to the three-to-four week intervals used in the clinical trials and recommended by Health Canada. NACI stated ...
The Canadian government anticipates that at least 95 per cent of the Canadian population will be able to receive a COVID-19 vaccine by the end of the third quarter of the year, between July and ...
Vaccine Progress Doses ordered Approval Deployment Pfizer–BioNTech: phase III clinical trials 51-76 million [1] [2] [3] 9 December 2020 [4] 14 December 2020 Moderna: phase III clinical trials 44 million [5] 23 December 2020 [6] 31 December 2020 Oxford–AstraZeneca: phase III clinical trials 23.9 million [7] 26 February 2021 [8] 10 March 2021 [9]
The COVID-19 vaccination campaign in Quebec (French: Campagne de vaccination contre la Covid-19 au Québec) was a provincial effort to distribute and administer vaccines against COVID-19. Quebec received their first shipments of COVID-19 vaccines on December 13, 2020. [ 2 ]
[23] [24] By the end of July 2021, Canada had received a cumulative total of more than 66.4 million vaccines. [25] [26] By August 2021, Canada had attained the highest vaccination rate in the world. [24] Anand also worked to finalize Canada's agreements with vaccine producers regarding the procurement and delivery of COVID-19 vaccine doses for ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...